DossierENTITY

specialty drugs

Coverage of specialty drugs in the Nexus archive.

Earliest in view: Jul 30 · 13:10 UTCMost recent: Jul 30 · 13:10 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 30 · 13:10 UTCQUARTZ
Cigna is raising its annual profit forecast on specialty drug strength
Cigna is raising its annual profit forecast due to strength in specialty drugs. The health company now expects full-year adjusted earnings of at least $30.45 per share, an increase of 10 cents from its previous outlook.